Sign in to view content

Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema

Peter K. Kaiser, MD FASRS

Video
Published 2018

Related

Assessing Commercially Available Cell Therapies for Retinal Disease in the U.S.
Ajay E Kuriyan, MD, MS
Daniel Simhaee, MD
Updates from the Field
2018
Multilayered Inverse Internal Limiting Membrane Peeling – Is ILM the Culprit or Savior in the Treatment of Large Macular Holes and Macular Hole R.D.?
Srinivas Joshi, MD, FASRS
Annual Meeting Talks
2018
Improvement of Worsening in Diabetic Retinopathy Through 2 Years in a Randomized Trial
Susan B. Bressler, MD, FASRS
Updates from the Field
2017

Category: Diabetic Retinopathy

See more